- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Luminex Corp (LMNX)
| Open: | 18.2300 | Day's Range: | 18.2200 - 18.5900 | Volume: | 325,127 |
|---|---|---|---|---|---|
| Previous Close: | 18.1100 | 52wk Range: | 15.3900 - 25.7900 | 1-Yr Rtn: | -17.03% |
Key Statistics for LMNX
| Current P/E Ratio (ttm) | 63.4828 |
|---|---|
| Estimated P/E(12/2013) | 38.0372 |
| Relative P/E vs. SPX | 3.8908 |
| Earnings Per Share (USD) (ttm) | 0.2900 |
| Est. EPS (USD) (12/2013) | 0.4840 |
| Est. PEG Ratio | 1.5849 |
| Market Cap (M USD) | 765.62 |
| Shares Outstanding (M) | 41.59 |
| 30 Day Average Volume | 198,979 |
| Price/Book (mrq) | 2.9680 |
| Price/Sale (ttm) | 3.6376 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LMNX
Company Profile & Key Executives for LMNX
Luminex Corporation develops, manufactures and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The Company's open-architecture technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly and accurately.
| Patrick J Balthrop SrPresident/CEO | Jeremy K Bridge-CookSenior VP:Research & Dev |
| Michael F PintekSenior VP:Operations | David S ReiterVP/Secy/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LMNX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page